Cancer Drug Conatumumab Shows Promise for Peripheral Artery Disease Treatment

Pre-clinical Study Suggests Conatumumab Can Promote Blood Flow Restoration in PAD Patients

Topline:

A recent pre-clinical study suggests that the cancer drug Conatumumab may offer a new treatment option for patients suffering from Peripheral Artery Disease (PAD) by promoting the growth of new blood vessels and restoring blood flow.

Peripheral Artery Disease (PAD), a condition characterized by the narrowing of arteries in the lower limbs, often…